Who Paid My Doc
Philip Meyers
Vascular & Interventional Radiology New York, NY Medical Doctor
NPI 1033119458 CMS profile 183254
710 W 168Th St, Neurological Institute, Rm 404, New York, NY 10032
General payments
$237,679
Research payments
$400
Ownership & investment interest
$0
Research they led as principal investigator
$53,213
Through program year 2025, Philip Meyers of New York, NY is reported in the CMS Open Payments database as having received $237,679 across 213 general payments and $400 in research payments paid to them. Separately, studies naming them as principal investigator received $53,213 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $41,567 | 22 | |
| 2024 | General | $41,306 | 31 | |
| 2023 | General | $53,931 | 50 | |
| 2022 | General | $37,184 | 31 | |
| 2021 | General | $23,672 | 31 | |
| 2020 | General | $23,661 | 24 | |
| 2019 | General | $16,359 | 24 | |
| 2019 | Research | $400 | 1 |
Beside peers
- Philip Meyers
- Vascular & Interventional Radiology median
- Middle half of Vascular & Interventional Radiology
- National median
In program year 2025, general payments to Philip Meyers were reported at $41,567. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.
Show as a table
| Year | Philip Meyers | Vascular & Interventional Radiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $16,359 | $422 | $125–$1,555 | $163 |
| 2020 | $23,661 | $200 | $68–$652 | $114 |
| 2021 | $23,672 | $280 | $99–$866 | $132 |
| 2022 | $37,184 | $433 | $137–$1,497 | $149 |
| 2023 | $53,931 | $506 | $152–$2,019 | $160 |
| 2024 | $41,306 | $556 | $175–$1,930 | $164 |
| 2025 | $41,567 | $534 | $166–$2,075 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
214 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Vascular & Interventional Radiology in New York
Edward Kim
Vascular & Interventional Radiology · New York, NY
Gary Siskin
Vascular & Interventional Radiology · Albany, NY
Robert Lookstein
Vascular & Interventional Radiology · New York, NY
Craig Greben
Vascular & Interventional Radiology · Manhasset, NY
Anuj Malhotra
Vascular & Interventional Radiology · Albany, NY
Rahul Patel
Vascular & Interventional Radiology · New York, NY
Related records
Vascular & Interventional Radiology in New York
Practitioners in the same specialty and state, ranked by reported value.
All Vascular & Interventional Radiology
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.